Atlanta, GA-- Paul Hastings, a leading global law firm, announced today that the firm represented Novella Clinical, a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors, in its agreement to merge with Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services.

The terms of the transaction were not disclosed and the transaction is subject to customary closing conditions.

Healthcare transaction counsel W. Craig Smith led the Paul Hastings team, which included Antitrust and Competition partner C. Scott Hataway, Benefits partner Eric Keller, Employment partners C. Geoffrey Weirich and Suzanne Horne, Tax partner Philip Marzetti and corporate associates Brian Teras and Matthew Poxon.